Home › Clinical Tools › SAMe-TT₂R₂

💊 SAMe-TT₂R₂ Score (VKA TTR)

UseWhen to use: discussing VKA versus DOAC when TTR quality is uncertain.

Loading calculator…

StrataScores ≥2 associate with poorer TTR — consider DOAC or intensified INR monitoring if VKA used.

LimitsWhen not to use: replacing shared decision-making / local formulary. · Pitfall: ignoring bleeding risk scores. · Not a DOAC mandate.

SourceSAMe-TT₂R₂ (Apostolakis) published score

Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders

This-shift next steps

After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Methodology · worked example, guidelines & full notes
Clinical takeaway

Max 8; ≥2 poorer TTR cue.

When to use

When to use: discussing VKA versus DOAC when TTR quality is uncertain.

How it works

Female +1; age <60 +1; ≥2 comorbidities +1; interacting Rx +1; tobacco ≤2 y +2; non-white +2 (max 8).

Key points

  • Max 8; ≥2 poorer TTR cue.
  • AF VKA quality aid.
  • Next: HAS-BLED / DOAC check.

References

  • SAMe-TT₂R₂ (Apostolakis) published score

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

Sex (female)No (male)
Age < 60 yearsNo
Medical history ≥2 comorbiditiesNo
Interacting treatment (e.g. amiodarone)No
Tobacco within 2 yearsNo
Non-white ethnicityNo

→SAMe-TT₂R₂0/8

  • Max:8
  • Cue:0–1 — likelier acceptable TTR if VKA chosen (still individualize)
Sex (female)Yes (female) +1
Age < 60 yearsYes +1
Medical history ≥2 comorbiditiesYes +1
Interacting treatment (e.g. amiodarone)Yes +1
Tobacco within 2 yearsYes +2
Non-white ethnicityYes +2

→SAMe-TT₂R₂8/8

  • Max:8
  • Cue:≥2 — higher chance of suboptimal TTR on VKA; consider DOAC / closer INR monitoring
Verification & sources · governance
FAQ

Frequently asked questions

Does SAMe-TT₂R₂ Score (VKA TTR) upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is SAMe-TT₂R₂ Score (VKA TTR) calculated in practice? Can you show a worked example?
Inputs: Sex (female) No (male), Age < 60 years No, Medical history ≥2 comorbidities No, Interacting treatment (e.g. amiodarone) No, Tobacco within 2 years No, Non-white ethnicity No → Result: SAMe-TT₂R₂ 0 /8(Max: 8, Cue: 0–1 — likelier acceptable TTR if VKA chosen (still individualize)) Inputs: Sex (female) Yes (female) +1, Age < 60 years Yes +1, Medical history ≥2 comorbidities Yes +1, Interacting treatment (e.g. amiodarone) Yes +1, Tobacco within 2 years Yes +2, Non-white ethnicity Yes +2 → Result: SAMe-TT₂R₂ 8 /8(Max: 8, Cue: ≥2 — higher chance of suboptimal TTR on VKA; consider DOAC / closer INR monitoring)
Related tools